Related Experiment Video
Updated: Aug 28, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Nutraceutical Prevention of Diabetic Complications-Focus on Dicarbonyl and Oxidative Stress
Mark F McCarty1, James J DiNicolantonio2, James H O'Keefe2
1Catalytic Longevity Foundation, San Diego, CA 92109, USA.
Abstract:
Oxidative and dicarbonyl stress, driven by excess accumulation of glycolytic intermediates in cells that are highly permeable to glucose in the absence of effective insulin activity, appear to be the chief mediators of the complications of diabetes. The most pathogenically significant dicarbonyl stress reflects spontaneous dephosphorylation of glycolytic triose phosphates, giving rise to highly reactive methylglyoxal. This compound can be converted to harmless lactate by the sequential activity of glyoxalase I and II, employing glutathione as a catalyst. The transcription of glyoxalase I, rate-limiting for this process, is promoted by Nrf2, which can be activated by nutraceutical phase 2 inducers such as lipoic acid and sulforaphane. In cells exposed to hyperglycemia, glycine somehow up-regulates Nrf2 activity. Zinc can likewise promote glyoxalase I transcription, via activation of the metal-responsive transcription factor (MTF) that binds to the glyoxalase promoter. Induction of glyoxalase I and metallothionein may explain the protective impact of zinc in rodent models of diabetic complications. With respect to the contribution of oxidative stress to diabetic complications, promoters of mitophagy and mitochondrial biogenesis, UCP2 inducers, inhibitors of NAPDH oxidase, recouplers of eNOS, glutathione precursors, membrane oxidant scavengers, Nrf2 activators, and correction of diabetic thiamine deficiency should help to quell this.
Insights
Diabetic complications stem from oxidative and dicarbonyl stress. Strategies targeting methylglyoxal detoxification and oxidative pathways, including Nrf2 activation and zinc, show promise for mitigating these issues.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Diabetes complications arise from oxidative and dicarbonyl stress due to excess glucose metabolism.
- Methylglyoxal, a reactive dicarbonyl compound, significantly contributes to diabetic pathology.
- Effective insulin activity is crucial for regulating glucose metabolism and preventing stress accumulation.
Purpose of the Study:
- To explore the mechanisms underlying oxidative and dicarbonyl stress in diabetes.
- To identify key molecular targets and pathways for therapeutic intervention.
- To evaluate the potential of nutraceuticals and minerals in managing diabetic complications.
Main Methods:
- Investigated the role of methylglyoxal detoxification pathways, particularly the glyoxalase system.
- Examined the regulation of glyoxalase I transcription by Nrf2 and zinc-mediated pathways.
- Reviewed the impact of various compounds and interventions on oxidative stress markers and diabetic complications.
Main Results:
- Glyoxalase I, rate-limiting for methylglyoxal detoxification, is upregulated by Nrf2 activators (lipoic acid, sulforaphane, glycine) and zinc.
- Zinc promotes glyoxalase I and metallothionein transcription, potentially explaining its protective effects.
- Multiple strategies targeting oxidative stress, including mitophagy, UCP2 induction, and Nrf2 activation, are proposed.
Conclusions:
- Targeting methylglyoxal metabolism via glyoxalase I induction is a promising therapeutic strategy for diabetic complications.
- Nutraceuticals and minerals like zinc, acting through pathways like Nrf2, can mitigate diabetic stress.
- A multi-pronged approach addressing both dicarbonyl and oxidative stress is essential for managing diabetes complications.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Coronary Artery Disease I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Atherosclerosis III: Management

